Oncology pharma stock price.

Oncology Pharma Inc. ONPH:US. Otc Us (USD) · Market closed. 0.00. –0.00 –99.00% As of 5:20 PM EDT 05/14/24. Prev. close. 0.00 USD. 3:46 PM. 3:46p …

Oncology pharma stock price. Things To Know About Oncology pharma stock price.

DVAX Dynavax Technologies Corporation. 11.03. +2.80%. Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.6 brokers have issued 1-year price objectives for ALX Oncology's stock. Their ALXO share price targets range from $11.00 to $27.00. On average, they predict the company's share price to reach $18.83 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price.ONPH: Oncology Pharma - Full Company Report. Get the latest Full Company Report for Oncology Pharma from Zacks Investment Research

A high-level overview of Olema Pharmaceuticals, Inc. (OLMA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Surface Oncology (SURF) raised $84 million in an IPO on Thursday, April 19th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI served as the underwriters for the IPO. This page (NASDAQ:SURF) was last updated on 5/14/2024 by MarketBeat.com Staff.Their OLMA share price targets range from $18.00 to $28.00. On average, they predict the company's stock price to reach $21.67 in the next year. This suggests a possible upside of 131.2% from the stock's current price. View analysts price targets for OLMA or view top-rated stocks among Wall Street analysts.

Current Stock Price for Oncology Pharma (ONPH)? A. The stock price for Oncology Pharma ( OTCEM: ONPH) is $ 0.000001 last updated May 8, 2024, 10:33 AM EDT. Q.

Like Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), and Johnson & Johnson (NYSE:JNJ), Amgen Inc. (NASDAQ:AMGN) is one of the best cancer stocks to buy. ClearBridge Large Cap Value Strategy ...You can trade Oncology Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account. What are Oncology Pharma Inc. stock highest and lowest prices ever? ONPH reached its all-time high on Aug 16, 2013 with the price of 375000.0000 USD, and its all-time low was 0.000001 USD and was reached on Nov 8, 2023.Between in or about January and July 2021, Oncology Pharma, Inc. was a thinly traded company that traded on the over-the-counter securities market. In January 2021, Padilla engaged in manipulative trading in ONPH designed, at least in part, to artificially drive up the company’s stock price.3 Wall Street research analysts have issued 1-year target prices for Ikena Oncology's shares. Their IKNA share price targets range from $8.00 to $11.00. On average, they expect the company's stock price to reach $9.50 in the next twelve months. This suggests a possible upside of 619.7% from the stock's current price.Oncology Pharma Inc (ONPH) stock is trading at $11.71 as of 9:38 AM on Monday, Sep 20, a drop of -$2.28, or -16.3% from the previous closing price of $13.99. The stock has traded between $11.54 and $14.24 so far today. Volume today is below average. So far 42,391 shares have traded compared to average volume of 227,400 shares.

The shares in Ascelia Pharma are traded on Nasdaq Stockholm (main market, small cap) under the ticker “ACE”. ISIN-code is SE0010573113. Share price is shown ...

Sierra Oncology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Takeda Pharmaceutical Ltd ADR: NBIX : 141.71 -0.87% : Neurocrine Bioscienc: UTHR : 260.51 +21.20% : ... (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return ...

Share Price History ; 13 May, 2024, $1.55, +0.14, +9.93%, $1.425 ; 10 May, 2024, $1.41, +0.095, +7.22%, $1.315.Oncology Pharma Research and Vision. 01:02pm, Tuesday, 30'th Nov 2021 InvestorsHub. San Francisco, CA -- November 30, 2021 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is a pioneering oncology company dedicated to providing the financing and the tools to …Oncology Pharma (ONPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Stock split history for Oncology Pharma since . Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Market Average Movement. 6.1%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: ONPH's share price has been volatile over the past 3 months. Volatility Over Time: ONPH's weekly volatility has decreased from 303791% to 186068% over the past year, but is still higher than 75% of US ...Oncology Pharma Inc. analyst estimates, including ONPH earnings per share estimates and analyst recommendations. ... Stock Price Targets. High: N/A: Median: N/A: Low: N/A: Average: N/A: Current ...

Get real-time updates on Oncology Pharma (ONPH) stock quotes, trades, and more. Make informed investments with Nasdaq. A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Amgen stock opened the day at $301.75 after a previous close of $299.48. The latest price was $300.30 (25-minute delay). Amgen is listed on the NASDAQ, has a trailing 12-month revenue of around USD28.2 billion and employs 26,700 staff. Market capitalization: $148,774,600,704.May 1, 2024 · The Best Biotech Stocks of May 2024. Company (TICKER) 5-Year Average Annual EPS Forecast. Biomarin Pharmaceuticals Inc. (BMRN) 43.0%. Halozyme Therapeutics, Inc. (HALO) 25.0%. Incyte Corporation ... See the latest Oncology Pharma Inc stock price (ONPH:PINX), related news, valuation, dividends and more to help you make your investing decisions.Stock analysis for Oncology Pharma Inc (SNET:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Get the latest Oncology Pharma Inc. (ONPH) stock news and headlines to help you in your trading and investing decisions.

24.46. -1.61%. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Olema Pharmaceuticals Inc (OLMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Market Average Movement. 6.1%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: ONPH's share price has been volatile over the past 3 months. Volatility Over Time: ONPH's weekly volatility has decreased from 303791% to 186068% over the past year, but is still higher than 75% of US ...Find the latest Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Olema Pharmaceuticals Inc (OLMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.May 9, 2024 · A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Oncology Pharma PE ratio based on its reported earnings over the past 12 months is null.The shares last closed at $0.00.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.Oncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and Dates benzinga.com - February 27 at 10:00 AM: Oncology Pharma Stock (OTC:ONPH), Analyst Ratings, Price Targets, Predictions benzinga.com - February 27 at 10:00 AM: The doctor behind the next big thing in cancer treatment msn.com - February 20 at 11:34 PMOpen. 0.00. Day Low. 0.00. Day High. 0.00. 52 Wk Low. 0.00. 52 Wk High. 1.05. 20 Day Avg Vol. 4,226. Market Cap. NA. Dividend. 0.00 ( 0.00%) Beta. NA. Key …When you place a limit order, you are essentially setting a "limit" on the price you are willing to pay (or receive) for the stocks. For example, if you want to buy shares of Oncology Pharma, you could place a limit order to buy at $0.0001 per share. If the price of Oncology Pharma drops to $0.0001 or less, your order will be executed.Pfizer ( PFE -0.21%) currently markets three blockbuster oncology therapies -- breast cancer drug Ibrance, prostate cancer drug Xtandi, and kidney cancer drug Inlyta. The company also has a dozen ...

View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Oncology Pharma (ONPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Oncology Pharma Inc (ONPH) $0.0001 0.00 (0.00%) 15:55 EST ONPH Stock Quote Delayed 30 Minutes.Find the latest ALX Oncology Holdings Inc. (ALXO) stock quote, history, news and other vital information to help you with your stock trading and investing.6m. YTD. 1y. 5y. Max. Full screen. Trade prices are not sourced from all markets. All. News. Press releases. Find the latest Oncology Pharma Inc. (ONPH) stock quote, …Find the latest Oncology Pharma Inc. (ONPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Get the latest Phio Pharmaceuticals Corp (PHIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. CRNXCrinetics Pharmaceuticals, Inc. 48.00. -2.87%. YMABY-mAbs Therapeutics, Inc. 12.28. -4.58%. Find the latest Kura Oncology, Inc. (KURA) stock quote, history, news and other vital information to ... View today's Oncology Pharma Inc stock price and latest ONPH news and analysis. Create real-time notifications to follow any changes in the live stock price.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.View today's Oncology Pharma Inc stock price and latest ONPH news and analysis. Create real-time notifications to follow any changes in the live stock price.Oncology Pharma Inc Registered Shs. 0.00. 0.00. USD. *Yield of the Respective Date. The latest Oncology Pharma stock prices, stock quotes, news, and ONPH history to help you invest and trade smarter.

Stock analysis for Oncology Pharma Inc (SNET:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Shares 1, 40,706,972, Green Equity Designation, No, Week, -5.71. Mkt Cap of share series 2, Green Equity Transition Designation, No, Month, -49.23.A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Instagram:https://instagram. betty bohmerreserve at nocateehow much is 2 grams of salt in teaspoonsmontvale chinese 24.46. -1.61%. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other vital information to help you with your stock trading and investing. julia's bakery murfreesboro tnolive garden catering menu prices Sierra Oncology, Inc. (SRRA.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Sierra Oncology, Inc. | Nasdaq: SRRA ... vault designer logistics A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.7 brokers have issued 1 year target prices for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they predict the company's stock price to reach $28.79 in the next year. This suggests a possible upside of 118.7% from the stock's current price.